Common Stock, Shares, Outstanding of Regen BioPharma Inc from Q3 2013 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Regen BioPharma Inc quarterly Common Stock, Shares, Outstanding history and change rate from Q3 2013 to Q2 2025.
  • Regen BioPharma Inc Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2025 was 31.6M shares, a 622% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 31.6M +27.2M +622% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 21.6M +17.4M +424% 31 Mar 2025 10-Q 28 May 2025
Q4 2024 21.6M +17.8M +475% 31 Dec 2024 10-Q 16 May 2025
Q3 2024 5.26M +1.75M +50% 30 Sep 2024 10-Q 11 Aug 2025
Q2 2024 4.37M +992K +29.3% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 4.11M +733K +21.7% 31 Mar 2024 10-Q 24 Apr 2024
Q4 2023 3.75M -50.8B -100% 31 Dec 2023 10-Q 19 Jan 2024
Q3 2023 3.51M +152K +4.52% 30 Sep 2023 10-K 13 May 2025
Q2 2023 3.38M -4.92B -99.9% 30 Jun 2023 10-Q 25 Jul 2023
Q1 2023 3.38M -4.58B -99.9% 31 Mar 2023 10-Q 18 Apr 2023
Q4 2022 50.8B +46.3B +1014% 31 Dec 2022 10-Q 19 Jan 2023
Q3 2022 3.35M -4.35B -99.9% 30 Sep 2022 10-K 13 May 2025
Q2 2022 4.92B +1.14B +30.2% 30 Jun 2022 10-Q 22 Jul 2022
Q1 2022 4.58B +1.65B +56.1% 31 Mar 2022 10-Q 21 Apr 2022
Q4 2021 4.56B +2.3B +102% 31 Dec 2021 10-Q 20 Jan 2022
Q3 2021 4.35B +2.75B +171% 30 Sep 2021 10-K 15 Nov 2022
Q2 2021 3.78B +2.18B +136% 30 Jun 2021 10-Q/A 22 Dec 2021
Q1 2021 2.93B +2.77B +1728% 31 Mar 2021 10-Q 18 Aug 2021
Q4 2020 2.26B +838M +58.9% 31 Dec 2020 10-Q 13 Aug 2021
Q3 2020 1.61B +1B +167% 30 Sep 2020 10-K 22 Dec 2021
Q2 2020 1.61B +1.09B +210% 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 161M -217M -57.4% 31 Mar 2020 10-Q 05 Aug 2021
Q4 2019 1.42B +1.17B +464% 31 Dec 2019 10-Q 05 Aug 2021
Q3 2019 600M +420M +233% 30 Sep 2019 10-Q 05 Aug 2021
Q2 2019 518M +360M +227% 30 Jun 2019 10-Q 24 Oct 2019
Q1 2019 377M +226M +149% 31 Mar 2019 10-Q 29 Aug 2019
Q4 2018 252M +106M +72.4% 31 Dec 2018 10-Q 12 Feb 2019
Q3 2018 180M +40.6M +29.1% 30 Sep 2018 10-K 21 Jun 2021
Q2 2018 159M +20.6M +14.9% 30 Jun 2018 10-Q 06 Aug 2018
Q1 2018 151M +13.2M +9.57% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 146M +768K +0.53% 31 Dec 2017 10-Q 06 Feb 2018
Q3 2017 140M -8.45K -0.01% 30 Sep 2017 10-K 27 Dec 2018
Q2 2017 138M +3.56M +2.65% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 138M +9.86M +7.69% 31 Mar 2017 10-Q 05 May 2017
Q4 2016 145M +30.7M +26.7% 31 Dec 2016 10-Q 27 Jan 2017
Q3 2016 140M +25M +21.8% 30 Sep 2016 10-Q 27 Jan 2017
Q2 2016 135M +25.2M +23.1% 30 Jun 2016 10-Q 01 Aug 2016
Q1 2016 128M +18.9M +17.3% 31 Mar 2016 10-Q/A 28 Apr 2017
Q4 2015 115M +62.7M +120% 31 Dec 2015 10-Q 28 Jan 2016
Q3 2015 115M +63.1M +122% 30 Sep 2015 10-Q/A 28 Apr 2017
Q2 2015 109M +57.4M +111% 30 Jun 2015 10-Q/A 28 Apr 2017
Q1 2015 109M +57.4M +111% 31 Mar 2015 10-Q 07 May 2015
Q4 2014 52M 31 Dec 2014 10-Q 04 Feb 2015
Q3 2014 51.6M 0 0% 30 Sep 2014 10-K/A 28 Apr 2017
Q2 2014 51.9M 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 51.9M 31 Mar 2014 10-Q 05 May 2014
Q3 2013 51.6M 30 Sep 2013 10-K 18 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.